Looks Health Services Ltd.
Snapshot View

View in App

Prices View details >>

4.00 -0.05 ▼-1.2%

29 March 2023, 04:01:00 PM
Volume: 43,040

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.looksclinic.in
Market Cap 4.20 Cr.
Enterprise Value(EV) 4.20 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 0.01 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 420.00 Trailing Twelve Months Ending 2022-12
Industry PE 46.43 Trailing Twelve Months Ending 2022-12
Book Value / Share 14.28 Trailing Twelve Months Ending 2022-12
Price to Book Value 0.28 Calculated using Price: 4.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.05 Cr. 10,500,000 Shares
FaceValue 10
Company Profile
The company operates only in one segment viz. Cosmetic & Non Cosmetic Treatments.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.23%
1 Week
-18.86%
1 Month
-34.96%
3 Month
-42.86%
6 Month
-54.13%
1 Year
-65.52%
2 Year
-36.20%
5 Year
-75.68%
10 Year
-96.76%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -0.03 -1.13 0.60 0.04 2.08 1.58 -0.11 -1.15 0.21
Return on Capital Employed (%) 0.08 -0.98 1.42 0.09 1.65 2.30 0.08 -0.55 0.26
Return on Assets (%) -0.03 -1.08 0.58 0.03 1.59 1.55 -0.11 -1.14 0.21

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 15 14 15 15 15 15 15 15 15 15
Non Curr. Liab. 0 0 0 8 0 0 0 0 0 0
Curr. Liab. 0 0 0 0 0 0 0 0 0 0
Minority Int.
Equity & Liab. 15 15 15 23 15 15 15 15 15 15
Non Curr. Assets 9 14 15 23 14 15 15 15 15 15
Curr. Assets 6 1 0 0 1 0 0 0 0 0
Misc. Exp. not W/O 0 0 0
Total Assets 15 15 15 23 15 15 15 15 15 15

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 2 2 2 2 2 1 1 0 0
Other Income 1 1 1 1 1 1 1 1 0 0
Total Income 3 3 3 2 2 2 1 1 0 0
Total Expenditure -3 -3 -2 -2 -2 -1 -1 0 0 0
PBIDT 0 0 0 0 1 1 0 0 0 0
Interest 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0
Exceptional Items 0
PAT 0 0 0 0 0 0 0 0 0
Adjusted EPS 0 0 0 0 0 0 0 0 0

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 1 2 -1 0 0 0 0 0 0
Cash Fr. Inv. -12 -1 -1 1 0 1 1 0 1 0
Cash Fr. Finan. 11 0 0 -1 0 0
Net Change 0 0 0 0 0 0 -1 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 1 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 21.17 21.17 21.17 21.17 21.17 21.17 21.17 21.17 21.17
Public 78.83 78.83 78.83 78.83 78.83 78.83 78.83 78.83 78.83
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 27 Mar 2023
Closure of Trading Window
This is to inform you that with reference to the circular no. LIST/COMP/01/2019-20 dated 02nd April 2019 issued by BSE Limited and pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended and in accordance with the Code of Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Designated Persons the Trading Window for dealing in securities/ shares of the Company shall remain closed from 01st April 2023 for all the Designated Persons and their immediate relative(s). The Trading Window will be open 48 hours after the announcement of the Audited financial results of the Company for the Quarter ended 31st March 2023.
Sat, 11 Feb 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed copies of the advertisement of Unaudited Financial Results for the quarter and Nine Months ended 31st December 2022 published in Mumbai Edition of Business Standard an English Daily and Mumbai Lakshadeep a Regional Daily on Saturday 11th February 2023.
Fri, 10 Feb 2023
Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2022
Pursuant to Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended from time to time the board has considered and approved the below amongst other businesses:

1. Unaudited Financial Results and Limited Review Report issued by M/s. Parekh Shah & Lodha Statutory Auditors of the Company for the quarter and nine months ended 31st December 2022 are enclosed herewith.

The board meeting commenced at 12:00 noon and concluded at 12:45 pm.

Technical Scans View Details >>

Wed, 29 Mar 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 237,702.12 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. 76,011.65 4,564.50 +0.8%
Divi's Laboratories Ltd. 74,827.63 2,818.70 +0.5%
Cipla Ltd. 71,662.87 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. 62,756.97 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. 52,113.83 1,554.65 +0.7%
Zydus Lifesciences Ltd. 49,628.37 490.30 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.44 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.86 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 31.22 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 27.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 82.20 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.32 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.08 490.30 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.36 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.37 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 5.66 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 3.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.90 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 7.53 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.77 490.30 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 490.30 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 490.30 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 490.30 +1.2%

FAQ's On Looks Health Services Ltd.

What is Looks Health Service share price?
Can I buy Looks Health Service shares now?
What is the Market Cap of Looks Health Service?
What are the key metrics to analyse Looks Health Service?
What is the 52 Week High and Low of Looks Health Service?
What is the trend of Looks Health Service share price?